Mr. Speaker, as I have already mentioned, Genome Canada has two five year contracts. It is in year three of those five year contracts. It is receiving $106 million this year and $108 million next year. In fact, it has the funding to carry it through to March 2013. The member needs to get his facts correct.
In the House of Commons on January 29th, 2009. See this statement in context.